Beta-Defensin vs Thymalin
A side-by-side research comparison of Beta-Defensin and Thymalin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Beta-Defensin | Thymalin |
|---|---|---|
| Full name | Human Beta-Defensin Peptides | Thymalin (Thymus Extract Peptide) |
| Category | Immune Support | Immune Support |
| Status | Research compound | Research compound |
| Mechanism | Form pores in microbial membranes causing lysis, recruit immune cells via CCR6 receptor chemotaxis, and bridge innate and adaptive immunity by activating dendritic cells. | Contains bioactive thymic peptides that regulate T-lymphocyte differentiation, restore T-helper/T-suppressor ratios, and enhance phagocyte activity and interferon production. |
| Molecular weight | 4000-5000 Da | ~1000-5000 Da (complex mixture) |
| Half-life | ~2-4 hours | ~4-6 hours |
| Bioavailability | Primarily local/mucosal activity | ~80% intramuscular |
| Typical dose | 50-200 mcg | 5-10 mg |
| Frequency | Daily or as needed | Daily for 5-10 days |
| Route | Topical or subcutaneous | Intramuscular injection |
Beta-Defensin reported benefits
- Broad antimicrobial activity
- Immune cell recruitment
- Wound healing support
- Biofilm disruption
Thymalin reported benefits
- Immune reconstitution
- T-cell ratio normalization
- Interferon production
- Anti-tumor immunity support
Related comparisons
Research and educational reference only. Not medical advice.